PharmaTelevision - BIOTECanada: Why Firms Should Invest In Canadian Biotechs

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BIOTECanada: Why Firms Should Invest In Canadian Biotechs

Visitors: You are watching a 30 seconds preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks with Peter Brenders, CEO at BIOTECanada.

Filmed at AusBiotech 2009, they discuss:

• BIOTECanada's role within the structure of the biotech sector in Canada
• The effect of 2009's global economic problems on Canada's biotech sector
• the increase in external VC investment in recent years.
• what makes Canada an attractive place to biotech companies
• issues within retaining Canadian talent
• what's to come for Canadian biotechs in 2010

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

BIOTECanada's role within the structure of the biotech sector in Canada

Fintan Walton:

Hello and welcome to PharmaTelevision news review here in Melbourne, Australia. On this show I have Peter Brenders, who is President and CEO of BIOTECanada based in Ottawa, welcome to the show.

Peter Brenders:

Thank you for having me.

Fintan Walton:

Peter Brenders, BIOTECanada is the national organization for biotechnology within Canada. You are based in Ottawa primarily because you are the national body, could you tell us about the origins of BIOTECanada and it's real purpose?

Peter Brenders:

BIOTECanada is the national voice for biotechnology. We represent the broad spectrum of biotechnology from health through agricultural, to industrial. We represent the companies within the country to basically support their commercial development of biotechnology and to help Canada get sort of get a footprint in the world.

Fintan Walton:

So, when people look at Canada, it's made up of various provinces those provinces are quite strong in their own voice and so forth, so how does an organization like BIOTECanada which operates nationally interact with the provinces and particularly work with the local biotech associations?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Peter Brenders

Chief Executive Officer

Peter Brenders joined BIOTECanada as President & CEO in February 2005. Previously, he worked in health affairs in senior management roles at Genzyme Canada and Schering-PloughCanada. Mr. Peter Brenders has also worked in the Ontario Ministry of Health and in the health consulting practice at KPMG. While at Genzyme, Mr. Peter Brenders served as Chair of the BIOTECanada Health Policy Committee and sat as a member of the association's Government Relations Committee. He is currently a Director of the DeGroote School of Business Alumni, McMaster University, a member of the Advisory Council for Algonquin College's biotechnology program, a former director of the Biotechnology Human Resources Council, and has served as a member of the Privy Council Office's Reference Group on Regulating, as a Board member and Treasurer of the Registered Nurses Association of Ontario Foundation, and has contributed to the Canadian College of Health Services Executives and served as the Chair of its Toronto Chapter. Mr. Peter Brenders received his MBA, in Health Services Management from McMaster University. Prior to his brief work in basic research at the Robarts Research Institute, he received his Honours BSc in Pharmacology and Toxicology from the University of Western Ontario.

BIOTECanada

BIOTECanada Incorporated in 1987 as the Industrial Biotechnology Association of Canada, BIOTECanada serves as the national voice for industry leadership for Canada's biotechnology sector. Through our national network of partner organizations, we inspire our domestic and international community to recognize the value of biotechnology and to provide solutions to the challenges faced by biotech firms today.